Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of KTN3379 in Adult Subjects With Advanced Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02014909
Recruitment Status : Completed
First Posted : December 18, 2013
Last Update Posted : July 24, 2017
Information provided by (Responsible Party):
Celldex Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 25, 2017
Actual Study Completion Date : June 5, 2017